Looking for a small stock with big return potential? Jim Cramer has an idea for you.
"An orphan drug is one that treats an incredibly rare disease," explained Jim Cramer. "In the United States that's a disease that afflicts less than 200,000 people, and in Europe, it's one that occurs in no more than 0.05% of the population."
Cramer realizes that may sound counter-intuitive – these drugs have a relatively small customer base, which suggests demand will never be a substantial catalyst. However, he believes there are other catalysts which will more than offset the demand issue.